Alyeska Investment Group, L.P. Portfolio Holdings

Alyeska Investment Group, L.P.

  • $25.4 Billion
  • Q2 2025

Alyeska Investment Group, L.P. has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $25.4 Billion distributed in 542 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ishares Core S&P 500 ETF with a value of $2.89B, Meta Platforms, Inc. with a value of $627M, Alphabet Inc. with a value of $412M, Microsoft Corp with a value of $395M, and Jpmorgan Chase & CO with a value of $387M.

Examining the 13F form we can see an increase of $2.03B in the current position value, from $23.4B to 25.4B.

Alyeska Investment Group, L.P. is based out at Chicago, IL

Below you can find more details about Alyeska Investment Group, L.P. portfolio as well as his latest detailed transactions.

Portfolio value $25.4 Billion
Technology: $5.17 Billion
Consumer Cyclical: $2.96 Billion
ETFs: $2.89 Billion
Industrials: $2.72 Billion
Communication Services: $2.44 Billion
Financial Services: $2.28 Billion
Healthcare: $2.06 Billion
Real Estate: $2 Billion
Other: $2.86 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$84B
$1.84 Million 0.01% of portfolio
17,424
Q2 2025 New
$740M
$3.11 Million 0.01% of portfolio
254,975
Q2 2025 Reduced 43.96%
$1.39B
$3.43 Million 0.01% of portfolio
70,000
Q2 2025 New
Gorilla Technology Group Inc
-
$0 0.0% of portfolio
-
Q2 2025 New
Hycroft Mining Holding Corp
-
$0 0.0% of portfolio
-
Q2 2025 New
In8 Bio Inc
-
$0 0.0% of portfolio
-
Q2 2025 New
Hinge Health Inc
-
$0 0.0% of portfolio
-
Q2 2025 New
Cantor Equity Partners Ii In
-
$0 0.0% of portfolio
-
Q2 2025 New
Cantor Equity Partners Iii I
-
$0 0.0% of portfolio
-
Q2 2025 New
Guardian Pharmacy Svcs Inc
-
$0 0.0% of portfolio
-
Q2 2025 Added 81.67%
Upstream Bio Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Gsk PLC
-
$0 0.0% of portfolio
-
Q2 2025 Added 81.81%
Ingram Micro Hldg Corp
-
$0 0.0% of portfolio
-
Q2 2025 Reduced 45.83%
Aldel Finl Ii Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
Karman Hldgs Inc
-
$0 0.0% of portfolio
-
Q2 2025 Reduced 66.67%
Beta Bionics Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
Jefferson Capital Inc
-
$0 0.0% of portfolio
-
Q2 2025 New
Traws Pharma Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 54.91%
$29.4B
$686,000 0.0% of portfolio
6,689
Q2 2025 Reduced 96.21%
Trisalus Life Sciences Inc
-
$0 0.0% of portfolio
-
Q2 2025 New
Twfg Inc
-
$0 0.0% of portfolio
-
Q2 2025 Reduced 19.65%
$202B
$317,000 0.0% of portfolio
585
Q2 2025 Reduced 99.81%
Intuitive Machines Inc
-
$0 0.0% of portfolio
-
Q2 2025 New
Intelligent Bio Solutions In
-
$0 0.0% of portfolio
-
Q1 2025 New
Camp4 Therapeutics Corp
-
$0 0.0% of portfolio
-
Q4 2024 New
Bunge Global Sa
-
$0 0.0% of portfolio
-
Q2 2025 New
Kenvue Inc
-
$0 0.0% of portfolio
-
Q2 2025 Reduced 25.82%
Usa Rare Earth Inc
-
$0 0.0% of portfolio
-
Q2 2025 New
Waystar Hldg Corp
-
$0 0.0% of portfolio
-
Q2 2025 New
$45.4B
$489,000 0.0% of portfolio
268
Q2 2025 New
Cg Oncology Inc
-
$0 0.0% of portfolio
-
Q2 2025 New
$1.31B
$478,000 0.0% of portfolio
10,922
Q2 2025 New
$43.1B
$609,000 0.0% of portfolio
1,739
Q2 2025 New
$34M
$256,000 0.0% of portfolio
235,705
Q1 2024 Reduced 45.9%
Etoro Group LTD
-
$0 0.0% of portfolio
-
Q2 2025 New
Diversified Energy Company P
-
$0 0.0% of portfolio
-
Q2 2025 Reduced 36.15%
Abacus Global Mgmt Inc
-
$0 0.0% of portfolio
-
Q2 2025 Reduced 4.38%
Coherent Corp
-
$0 0.0% of portfolio
-
Q2 2025 Added 79.17%
A2 Z Cust2 Mate Solutions Corp
-
$0 0.0% of portfolio
-
Q2 2025 Reduced 21.15%
Wns Hldgs LTD
-
$0 0.0% of portfolio
-
Q2 2025 New
$19M
$1.1 Million 0.0% of portfolio
1,663,355
Q4 2024 Reduced 0.02%
Core Scientific Inc New
-
$0 0.0% of portfolio
-
Q2 2025 New
Coreweave Inc
-
$0 0.0% of portfolio
-
Q2 2025 Added 31.82%
Crane Company
-
$0 0.0% of portfolio
-
Q2 2025 New
Achieve Life Sciences Inc
-
$0 0.0% of portfolio
-
Q2 2025 Added 732.38%
$77.8M
$1.09 Million 0.0% of portfolio
939,603
Q1 2024 Added 28.15%
Centuri Holdings Inc
-
$0 0.0% of portfolio
-
Q2 2025 New
Caris Life Sciences Inc
-
$0 0.0% of portfolio
-
Q2 2025 New
Genelux Corporation
-
$0 0.0% of portfolio
-
Q1 2025 New

Summary

  • Portfolio
  • No. of Stocks 542
  • Current Value $25.4 Billion
  • Prior Value $23.4 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 204 stocks
  • Additional Purchases 144 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 154 stocks
Track This Portfolio

Track Alyeska Investment Group, L.P. Portfolio

Follow Alyeska Investment Group, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alyeska Investment Group, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email